| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |